NAV3 and ovarian carcinoma: RNA-seq analysis of the 284 ovarian cancer samples available in “The Cancer Genome Atlas” (TCGA) data portal showed a significant correlation between miR-21-3p overexpression, NAV3 downregulation, and cisplatin resistance [20].